

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 6.36242195 |
| 2 | regulation of chronic inflammatory response (GO:0002676) | 5.86178353 |
| 3 | positive regulation of heat generation (GO:0031652) | 5.42907636 |
| 4 | regulation of fever generation (GO:0031620) | 5.34474395 |
| 5 | regulation of vitamin metabolic process (GO:0030656) | 5.04713854 |
| 6 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.98564123 |
| 7 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.93348322 |
| 8 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.89874797 |
| 9 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.76666911 |
| 10 | negative regulation of interleukin-12 production (GO:0032695) | 4.72760350 |
| 11 | regulation of mononuclear cell migration (GO:0071675) | 4.54789808 |
| 12 | regulation of chemokine biosynthetic process (GO:0045073) | 4.54349937 |
| 13 | response to peptidoglycan (GO:0032494) | 4.36056669 |
| 14 | regulation of podosome assembly (GO:0071801) | 4.35059075 |
| 15 | type I interferon signaling pathway (GO:0060337) | 4.24766140 |
| 16 | cellular response to type I interferon (GO:0071357) | 4.24766140 |
| 17 | monocyte chemotaxis (GO:0002548) | 4.23088178 |
| 18 | response to type I interferon (GO:0034340) | 4.18184608 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 4.16397709 |
| 20 | regulation of heat generation (GO:0031650) | 4.16009976 |
| 21 | eosinophil chemotaxis (GO:0048245) | 4.13580035 |
| 22 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.07631893 |
| 23 | myeloid dendritic cell differentiation (GO:0043011) | 4.04751566 |
| 24 | activation of MAPKKK activity (GO:0000185) | 4.03801311 |
| 25 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.96594082 |
| 26 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.90872150 |
| 27 | regulation of immunoglobulin secretion (GO:0051023) | 3.78378660 |
| 28 | response to protozoan (GO:0001562) | 3.77201129 |
| 29 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.73989452 |
| 30 | negative regulation of viral genome replication (GO:0045071) | 3.69756619 |
| 31 | NIK/NF-kappaB signaling (GO:0038061) | 3.69741899 |
| 32 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.68710328 |
| 33 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.67821802 |
| 34 | eosinophil migration (GO:0072677) | 3.66940088 |
| 35 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.63921036 |
| 36 | immunoglobulin mediated immune response (GO:0016064) | 3.59178883 |
| 37 | defense response to protozoan (GO:0042832) | 3.57360919 |
| 38 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.56649139 |
| 39 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.56530226 |
| 40 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.53451316 |
| 41 | myeloid dendritic cell activation (GO:0001773) | 3.51405652 |
| 42 | macrophage activation involved in immune response (GO:0002281) | 3.45967487 |
| 43 | T cell migration (GO:0072678) | 3.43328703 |
| 44 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.41680120 |
| 45 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.40719970 |
| 46 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.40345257 |
| 47 | T-helper 1 type immune response (GO:0042088) | 3.38753940 |
| 48 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.37786000 |
| 49 | cellular response to nicotine (GO:0071316) | 3.34793942 |
| 50 | positive regulation of interferon-alpha production (GO:0032727) | 3.34468932 |
| 51 | granulocyte activation (GO:0036230) | 3.33817599 |
| 52 | positive regulation of acute inflammatory response (GO:0002675) | 3.33127592 |
| 53 | negative regulation of amino acid transport (GO:0051956) | 3.31772805 |
| 54 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.30039846 |
| 55 | cellular response to lipopolysaccharide (GO:0071222) | 3.27539418 |
| 56 | germinal center formation (GO:0002467) | 3.25543987 |
| 57 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.25443255 |
| 58 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 3.21983508 |
| 59 | cellular response to molecule of bacterial origin (GO:0071219) | 3.14598771 |
| 60 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.14444989 |
| 61 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.12455270 |
| 62 | regulation of interleukin-12 production (GO:0032655) | 3.12362691 |
| 63 | regulation of NF-kappaB import into nucleus (GO:0042345) | 3.11905324 |
| 64 | lymphocyte chemotaxis (GO:0048247) | 3.10401868 |
| 65 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.10320878 |
| 66 | positive regulation of type 2 immune response (GO:0002830) | 3.08545882 |
| 67 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 3.07665183 |
| 68 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.06769624 |
| 69 | positive regulation of lymphocyte migration (GO:2000403) | 3.06109747 |
| 70 | negative regulation of growth of symbiont in host (GO:0044130) | 3.05450810 |
| 71 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.05450810 |
| 72 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.05450810 |
| 73 | regulation of growth of symbiont in host (GO:0044126) | 3.05450810 |
| 74 | positive regulation of interleukin-6 production (GO:0032755) | 3.04572691 |
| 75 | negative regulation of lipid storage (GO:0010888) | 3.03183296 |
| 76 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.02184577 |
| 77 | regulation of T-helper cell differentiation (GO:0045622) | 2.97846063 |
| 78 | dendritic cell differentiation (GO:0097028) | 2.97186559 |
| 79 | cellular response to interferon-gamma (GO:0071346) | 2.95306200 |
| 80 | macrophage chemotaxis (GO:0048246) | 2.94523332 |
| 81 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.93126408 |
| 82 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.91460036 |
| 83 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.90870923 |
| 84 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.89783692 |
| 85 | positive regulation of defense response to virus by host (GO:0002230) | 2.88794448 |
| 86 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.88444156 |
| 87 | response to muramyl dipeptide (GO:0032495) | 2.86052306 |
| 88 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.86048808 |
| 89 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.85950088 |
| 90 | neutrophil activation involved in immune response (GO:0002283) | 2.85714569 |
| 91 | oligosaccharide catabolic process (GO:0009313) | 2.82937349 |
| 92 | regulation of lymphocyte migration (GO:2000401) | 2.81204899 |
| 93 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.80733815 |
| 94 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.80309321 |
| 95 | regulation of type 2 immune response (GO:0002828) | 2.79709795 |
| 96 | positive regulation of interferon-beta production (GO:0032728) | 2.79526824 |
| 97 | virion attachment to host cell (GO:0019062) | 2.78668061 |
| 98 | adhesion of symbiont to host cell (GO:0044650) | 2.78668061 |
| 99 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.78303349 |
| 100 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.77542229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.97486274 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.95791726 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.39146830 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.42712906 |
| 5 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 4.32748902 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.72278211 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.69908238 |
| 8 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.41033882 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.34935374 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.34701660 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.14782439 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.03915151 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.02656035 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.81388491 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.81008049 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.66641343 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.52051431 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.40213549 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.19853154 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17283238 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.03658058 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.01193626 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.00285210 |
| 24 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.97672389 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89320017 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77915519 |
| 27 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.75133713 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.68854454 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.65977660 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64473609 |
| 31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61086658 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.60070965 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.57820784 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.56933011 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.55202291 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.54425973 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50026285 |
| 38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.47549159 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.46081684 |
| 40 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.45991594 |
| 41 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45449186 |
| 42 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44831838 |
| 43 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41855105 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.35862406 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32561385 |
| 46 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.32296545 |
| 47 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29994879 |
| 48 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.28789229 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28732880 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.27619559 |
| 51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23922760 |
| 52 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23117013 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20281988 |
| 54 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20216480 |
| 55 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20034836 |
| 56 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19194632 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19045090 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17457935 |
| 59 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.16844414 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.15735223 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.15015977 |
| 62 | MAF_26560356_Chip-Seq_TH2_Human | 1.14863900 |
| 63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.14399615 |
| 64 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11237915 |
| 65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06441818 |
| 66 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.06299666 |
| 67 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06277288 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06070188 |
| 69 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04671258 |
| 70 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04156422 |
| 71 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03492773 |
| 72 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02888424 |
| 73 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.02176893 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02097399 |
| 75 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.01081431 |
| 76 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98866981 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98186581 |
| 78 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96505534 |
| 79 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96475369 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96383010 |
| 81 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.95599996 |
| 82 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.95599996 |
| 83 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.95599996 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93266103 |
| 85 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92402658 |
| 86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91816867 |
| 87 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.90580667 |
| 88 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.90579813 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89574777 |
| 90 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89196658 |
| 91 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.88652267 |
| 92 | MYC_22102868_ChIP-Seq_BL_Human | 0.83661646 |
| 93 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81351274 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80051398 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.78706659 |
| 96 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.77119557 |
| 97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76959468 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.75472334 |
| 99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.72429983 |
| 100 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.72378080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 5.71777648 |
| 2 | MP0006082_CNS_inflammation | 4.34353210 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.78131599 |
| 4 | MP0009785_altered_susceptibility_to | 3.62984016 |
| 5 | MP0003436_decreased_susceptibility_to | 3.52593682 |
| 6 | MP0004510_myositis | 3.44157745 |
| 7 | MP0005671_abnormal_response_to | 3.19038458 |
| 8 | MP0003724_increased_susceptibility_to | 3.15295479 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.97266959 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.95126824 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.93332435 |
| 12 | MP0001790_abnormal_immune_system | 2.72119825 |
| 13 | MP0005387_immune_system_phenotype | 2.72119825 |
| 14 | MP0002139_abnormal_hepatobiliary_system | 2.60600158 |
| 15 | MP0009764_decreased_sensitivity_to | 2.57688139 |
| 16 | MP0005025_abnormal_response_to | 2.53016760 |
| 17 | MP0002419_abnormal_innate_immunity | 2.41324161 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.34566382 |
| 19 | MP0002723_abnormal_immune_serum | 2.24299371 |
| 20 | MP0001800_abnormal_humoral_immune | 2.20458024 |
| 21 | MP0003075_altered_response_to | 2.20180929 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.15661050 |
| 23 | MP0008004_abnormal_stomach_pH | 2.15354215 |
| 24 | MP0004947_skin_inflammation | 2.14260188 |
| 25 | MP0009840_abnormal_foam_cell | 2.10978252 |
| 26 | MP0001853_heart_inflammation | 2.02549906 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.98467051 |
| 28 | MP0005167_abnormal_blood-brain_barrier | 1.93675380 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.89571953 |
| 30 | MP0000343_altered_response_to | 1.87216398 |
| 31 | MP0006054_spinal_hemorrhage | 1.85593919 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.81106697 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.80554454 |
| 34 | MP0001819_abnormal_immune_cell | 1.80462614 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.78400849 |
| 36 | MP0005451_abnormal_body_composition | 1.75618669 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.74083916 |
| 38 | MP0002254_reproductive_system_inflammat | 1.73068587 |
| 39 | MP0009278_abnormal_bone_marrow | 1.70001205 |
| 40 | MP0003448_altered_tumor_morphology | 1.68258677 |
| 41 | MP0008469_abnormal_protein_level | 1.64810403 |
| 42 | MP0003453_abnormal_keratinocyte_physiol | 1.64132881 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.63198342 |
| 44 | MP0003806_abnormal_nucleotide_metabolis | 1.62799544 |
| 45 | MP0002405_respiratory_system_inflammati | 1.58528319 |
| 46 | MP0005310_abnormal_salivary_gland | 1.53081504 |
| 47 | MP0000604_amyloidosis | 1.51972048 |
| 48 | MP0000685_abnormal_immune_system | 1.46969424 |
| 49 | MP0003195_calcinosis | 1.44038853 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.41302697 |
| 51 | MP0005166_decreased_susceptibility_to | 1.40821413 |
| 52 | MP0003690_abnormal_glial_cell | 1.35774820 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.33013093 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.33013093 |
| 55 | MP0000716_abnormal_immune_system | 1.30785431 |
| 56 | MP0000858_altered_metastatic_potential | 1.27229753 |
| 57 | MP0001501_abnormal_sleep_pattern | 1.14588189 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.12938265 |
| 59 | MP0002398_abnormal_bone_marrow | 1.11989859 |
| 60 | MP0003763_abnormal_thymus_physiology | 1.11760563 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 1.10756221 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.06462491 |
| 63 | MP0009763_increased_sensitivity_to | 1.05782010 |
| 64 | MP0005165_increased_susceptibility_to | 0.99589406 |
| 65 | MP0002429_abnormal_blood_cell | 0.97595652 |
| 66 | MP0001542_abnormal_bone_strength | 0.95480937 |
| 67 | MP0009765_abnormal_xenobiotic_induced | 0.94419419 |
| 68 | MP0005164_abnormal_response_to | 0.93535394 |
| 69 | MP0000689_abnormal_spleen_morphology | 0.92550778 |
| 70 | MP0000920_abnormal_myelination | 0.91495347 |
| 71 | MP0002722_abnormal_immune_system | 0.87645692 |
| 72 | MP0005390_skeleton_phenotype | 0.86477866 |
| 73 | MP0003646_muscle_fatigue | 0.84093585 |
| 74 | MP0001873_stomach_inflammation | 0.83549188 |
| 75 | MP0005647_abnormal_sex_gland | 0.81410222 |
| 76 | MP0001663_abnormal_digestive_system | 0.81213829 |
| 77 | MP0010307_abnormal_tumor_latency | 0.80400835 |
| 78 | MP0002933_joint_inflammation | 0.76259668 |
| 79 | MP0003091_abnormal_cell_migration | 0.73931912 |
| 80 | MP0003191_abnormal_cellular_cholesterol | 0.73147897 |
| 81 | MP0008874_decreased_physiological_sensi | 0.69867058 |
| 82 | MP0005535_abnormal_body_temperature | 0.69840384 |
| 83 | MP0005266_abnormal_metabolism | 0.63092827 |
| 84 | MP0004808_abnormal_hematopoietic_stem | 0.62337644 |
| 85 | MP0005666_abnormal_adipose_tissue | 0.59410824 |
| 86 | MP0003183_abnormal_peptide_metabolism | 0.58990158 |
| 87 | MP0000249_abnormal_blood_vessel | 0.57674523 |
| 88 | MP0005023_abnormal_wound_healing | 0.57561015 |
| 89 | MP0003329_amyloid_beta_deposits | 0.56950256 |
| 90 | MP0003795_abnormal_bone_structure | 0.55941787 |
| 91 | MP0002837_dystrophic_cardiac_calcinosis | 0.54891939 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.54788009 |
| 93 | MP0001727_abnormal_embryo_implantation | 0.54373368 |
| 94 | MP0002693_abnormal_pancreas_physiology | 0.53581334 |
| 95 | MP0005076_abnormal_cell_differentiation | 0.52801756 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.52419796 |
| 97 | MP0004883_abnormal_blood_vessel | 0.52412623 |
| 98 | MP0001764_abnormal_homeostasis | 0.50067564 |
| 99 | MP0000609_abnormal_liver_physiology | 0.49709104 |
| 100 | MP0005595_abnormal_vascular_smooth | 0.45986432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.98192796 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.98192796 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 6.98192796 |
| 4 | Optic neuritis (HP:0100653) | 5.38959842 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 5.38959842 |
| 6 | Orchitis (HP:0100796) | 5.11606650 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.88655871 |
| 8 | Stomatitis (HP:0010280) | 4.77770533 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 4.51951016 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.51857300 |
| 11 | Disinhibition (HP:0000734) | 4.48038487 |
| 12 | Myositis (HP:0100614) | 4.47812916 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 4.38540999 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 4.31070267 |
| 15 | Loss of speech (HP:0002371) | 4.27346090 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 4.24081361 |
| 17 | Dysostosis multiplex (HP:0000943) | 4.21593470 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.88448287 |
| 19 | Nuclear cataract (HP:0100018) | 3.87032053 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.81578626 |
| 21 | Keratoconjunctivitis sicca (HP:0001097) | 3.69700012 |
| 22 | Mutism (HP:0002300) | 3.68650791 |
| 23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.44437441 |
| 24 | Eczematoid dermatitis (HP:0000976) | 3.40405507 |
| 25 | Keratoconjunctivitis (HP:0001096) | 3.37714399 |
| 26 | Gangrene (HP:0100758) | 3.35975555 |
| 27 | Neurofibrillary tangles (HP:0002185) | 3.32568700 |
| 28 | Pulmonary infiltrates (HP:0002113) | 3.25815980 |
| 29 | Vasculitis (HP:0002633) | 3.21412679 |
| 30 | Increased IgM level (HP:0003496) | 3.15532691 |
| 31 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.12824386 |
| 32 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.12824386 |
| 33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.12824386 |
| 34 | Autoimmune hemolytic anemia (HP:0001890) | 3.12758634 |
| 35 | Nausea (HP:0002018) | 3.05654980 |
| 36 | Parakeratosis (HP:0001036) | 3.03766210 |
| 37 | T lymphocytopenia (HP:0005403) | 2.96563120 |
| 38 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.95245389 |
| 39 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.89074667 |
| 40 | Increased serum ferritin (HP:0003281) | 2.88276464 |
| 41 | Abnormality of T cell number (HP:0011839) | 2.82825232 |
| 42 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.82549680 |
| 43 | Mucopolysacchariduria (HP:0008155) | 2.82549680 |
| 44 | Glomerulonephritis (HP:0000099) | 2.80838692 |
| 45 | Apathy (HP:0000741) | 2.78721260 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.78074238 |
| 47 | Hemoptysis (HP:0002105) | 2.69677920 |
| 48 | Recurrent viral infections (HP:0004429) | 2.69159061 |
| 49 | Axonal loss (HP:0003447) | 2.67829410 |
| 50 | Diminished motivation (HP:0000745) | 2.66321841 |
| 51 | Polyneuropathy (HP:0001271) | 2.65311574 |
| 52 | Agnosia (HP:0010524) | 2.63450470 |
| 53 | Hematochezia (HP:0002573) | 2.60378301 |
| 54 | Obstructive lung disease (HP:0006536) | 2.60166267 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.60166267 |
| 56 | Inappropriate behavior (HP:0000719) | 2.48870059 |
| 57 | Interstitial pulmonary disease (HP:0006530) | 2.48253375 |
| 58 | Progressive neurologic deterioration (HP:0002344) | 2.47897049 |
| 59 | Meningitis (HP:0001287) | 2.44717037 |
| 60 | Abnormality of the pleura (HP:0002103) | 2.44621331 |
| 61 | Amyloidosis (HP:0011034) | 2.44491150 |
| 62 | Arterial thrombosis (HP:0004420) | 2.42352596 |
| 63 | Encephalitis (HP:0002383) | 2.42036534 |
| 64 | Joint swelling (HP:0001386) | 2.39772062 |
| 65 | Purpura (HP:0000979) | 2.38093179 |
| 66 | Basal ganglia calcification (HP:0002135) | 2.37072765 |
| 67 | Recurrent skin infections (HP:0001581) | 2.35275090 |
| 68 | Cerebral inclusion bodies (HP:0100314) | 2.29390458 |
| 69 | Recurrent fungal infections (HP:0002841) | 2.27529668 |
| 70 | Hepatosplenomegaly (HP:0001433) | 2.26943615 |
| 71 | Abnormality of the pericardium (HP:0001697) | 2.25167667 |
| 72 | Abnormality of iron homeostasis (HP:0011031) | 2.22075901 |
| 73 | Neuronal loss in central nervous system (HP:0002529) | 2.21885328 |
| 74 | Anorexia (HP:0002039) | 2.21792247 |
| 75 | Complement deficiency (HP:0004431) | 2.20738073 |
| 76 | Hypergammaglobulinemia (HP:0010702) | 2.20555711 |
| 77 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.16671828 |
| 78 | Prolonged neonatal jaundice (HP:0006579) | 2.16439675 |
| 79 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.15851874 |
| 80 | IgA deficiency (HP:0002720) | 2.14679418 |
| 81 | Leukocytosis (HP:0001974) | 2.13665404 |
| 82 | Metaphyseal irregularity (HP:0003025) | 2.13222107 |
| 83 | Memory impairment (HP:0002354) | 2.12421759 |
| 84 | Abnormality of B cell number (HP:0010975) | 2.11937824 |
| 85 | Personality changes (HP:0000751) | 2.10850490 |
| 86 | Vertigo (HP:0002321) | 2.10278435 |
| 87 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.05541529 |
| 88 | Petechiae (HP:0000967) | 2.05392757 |
| 89 | Pulmonary embolism (HP:0002204) | 2.05358755 |
| 90 | Gastrointestinal stroma tumor (HP:0100723) | 2.01338599 |
| 91 | Glomerulopathy (HP:0100820) | 2.00485662 |
| 92 | B lymphocytopenia (HP:0010976) | 2.00007111 |
| 93 | Arthralgia (HP:0002829) | 1.99907952 |
| 94 | Myocardial infarction (HP:0001658) | 1.97445093 |
| 95 | Acne (HP:0001061) | 1.97020136 |
| 96 | Zonular cataract (HP:0010920) | 1.96018597 |
| 97 | Gastrointestinal infarctions (HP:0005244) | 1.93276519 |
| 98 | Combined immunodeficiency (HP:0005387) | 1.92246180 |
| 99 | Urticaria (HP:0001025) | 1.91147015 |
| 100 | Restrictive lung disease (HP:0002091) | 1.89787214 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 5.94170743 |
| 2 | GRK7 | 3.81690976 |
| 3 | NME2 | 3.62305893 |
| 4 | MAP3K14 | 3.52960886 |
| 5 | TAOK2 | 3.46339229 |
| 6 | TBK1 | 3.10721049 |
| 7 | TXK | 3.05514373 |
| 8 | DDR2 | 2.78558804 |
| 9 | RIPK1 | 2.56812470 |
| 10 | MAP4K1 | 2.49344519 |
| 11 | IKBKE | 2.46474492 |
| 12 | IKBKB | 2.43706263 |
| 13 | MATK | 2.41571122 |
| 14 | IRAK4 | 2.40906019 |
| 15 | TAOK1 | 2.39876109 |
| 16 | MAP3K11 | 2.38109462 |
| 17 | PIM2 | 2.23743137 |
| 18 | BLK | 2.16393949 |
| 19 | RIPK4 | 2.09811403 |
| 20 | MAP3K3 | 1.99794455 |
| 21 | BMPR2 | 1.98672296 |
| 22 | MOS | 1.86540257 |
| 23 | ADRBK2 | 1.74949906 |
| 24 | TYK2 | 1.74280721 |
| 25 | PRPF4B | 1.72109197 |
| 26 | CSK | 1.69439958 |
| 27 | FGR | 1.68043527 |
| 28 | CHUK | 1.57673876 |
| 29 | JAK3 | 1.47204301 |
| 30 | MAP2K3 | 1.41239263 |
| 31 | TGFBR2 | 1.34074129 |
| 32 | IRAK2 | 1.31256061 |
| 33 | IRAK1 | 1.20148781 |
| 34 | CDC42BPA | 1.18216084 |
| 35 | TYRO3 | 1.10457155 |
| 36 | MAP3K5 | 1.07644334 |
| 37 | ABL2 | 1.06069475 |
| 38 | SYK | 1.04522995 |
| 39 | LYN | 1.03656348 |
| 40 | MAP3K1 | 0.99970312 |
| 41 | ZAP70 | 0.98831091 |
| 42 | ACVR1B | 0.96684895 |
| 43 | JAK1 | 0.92413016 |
| 44 | ERN1 | 0.87004652 |
| 45 | LATS2 | 0.80638772 |
| 46 | LCK | 0.80010376 |
| 47 | JAK2 | 0.78052507 |
| 48 | STK10 | 0.77805033 |
| 49 | MAP2K6 | 0.75513508 |
| 50 | MARK3 | 0.75353305 |
| 51 | PIM1 | 0.74715372 |
| 52 | CSF1R | 0.72355970 |
| 53 | MAP3K13 | 0.70353597 |
| 54 | PKN1 | 0.67738889 |
| 55 | TESK2 | 0.64410487 |
| 56 | CLK1 | 0.63709246 |
| 57 | TAOK3 | 0.60646681 |
| 58 | BTK | 0.56122422 |
| 59 | ITK | 0.54341287 |
| 60 | DYRK3 | 0.52935799 |
| 61 | HCK | 0.47359644 |
| 62 | MAPK4 | 0.47151014 |
| 63 | FES | 0.45795923 |
| 64 | KDR | 0.41840454 |
| 65 | DAPK3 | 0.41428506 |
| 66 | PDGFRA | 0.41223910 |
| 67 | HIPK2 | 0.39755820 |
| 68 | SIK3 | 0.39449997 |
| 69 | BMX | 0.38278682 |
| 70 | ARAF | 0.37696536 |
| 71 | DAPK2 | 0.37352360 |
| 72 | CDK6 | 0.35156862 |
| 73 | KIT | 0.34723885 |
| 74 | TESK1 | 0.34467025 |
| 75 | INSR | 0.33059033 |
| 76 | EIF2AK2 | 0.28145063 |
| 77 | PRKCQ | 0.27027505 |
| 78 | CAMKK2 | 0.26640289 |
| 79 | TNK2 | 0.26631343 |
| 80 | ABL1 | 0.26487537 |
| 81 | SIK2 | 0.26300957 |
| 82 | EGFR | 0.25979318 |
| 83 | MAPK7 | 0.25304505 |
| 84 | PDK1 | 0.22168015 |
| 85 | PDGFRB | 0.21964836 |
| 86 | FYN | 0.21923127 |
| 87 | EPHA3 | 0.20781117 |
| 88 | DYRK1B | 0.18381934 |
| 89 | GSK3A | 0.16838963 |
| 90 | MAPKAPK2 | 0.15951680 |
| 91 | PRKCD | 0.15894849 |
| 92 | RPS6KC1 | 0.15800147 |
| 93 | RPS6KL1 | 0.15800147 |
| 94 | CDK14 | 0.15399331 |
| 95 | STK24 | 0.15241325 |
| 96 | PAK4 | 0.13013276 |
| 97 | CDK15 | 0.12383161 |
| 98 | ICK | 0.11954157 |
| 99 | RPS6KA1 | 0.11762249 |
| 100 | MAPK3 | 0.11635055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.24120116 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.09130545 |
| 3 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.04127230 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.02550718 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.90375825 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.75538309 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.61440317 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.58867976 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.51719388 |
| 10 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.51153322 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.51095390 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.47271397 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 2.44303190 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.33778890 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 2.28887854 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.28017191 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.26106924 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.23148374 |
| 19 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.17502072 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 2.17454962 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.17066971 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 2.13959181 |
| 23 | * Salmonella infection_Homo sapiens_hsa05132 | 2.13832311 |
| 24 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.91406013 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.90640091 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.85155034 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.76758472 |
| 28 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.73481872 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.66985817 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.61800139 |
| 31 | Measles_Homo sapiens_hsa05162 | 1.52133700 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48002256 |
| 33 | Prion diseases_Homo sapiens_hsa05020 | 1.43345498 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.42190748 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40307341 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.28524709 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.23975259 |
| 38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.18704278 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17706234 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.15615899 |
| 41 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12947750 |
| 42 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.11230532 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09857799 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.09686365 |
| 45 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.00432629 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.00310307 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 0.99922448 |
| 48 | Phagosome_Homo sapiens_hsa04145 | 0.98145127 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 0.93824819 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92775692 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86214524 |
| 52 | Amoebiasis_Homo sapiens_hsa05146 | 0.86047624 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84478487 |
| 54 | Bladder cancer_Homo sapiens_hsa05219 | 0.83284375 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82572532 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81547819 |
| 57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.78556493 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67455960 |
| 59 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67063263 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61545746 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60930066 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60097816 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59022263 |
| 64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.57942789 |
| 65 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57554581 |
| 66 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56342529 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52912670 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52909727 |
| 69 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.51847090 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47373883 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42876946 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38620291 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36052915 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33845640 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32213669 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.30086341 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30050477 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25722604 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.23937573 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.21813685 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.20599660 |
| 82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.20247669 |
| 83 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.19650606 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.19217954 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.15828237 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.14324866 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.12686562 |
| 88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.09854584 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.09087460 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.09056561 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.08844858 |
| 92 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.08607005 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.07956863 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.05601811 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.04333568 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.00716852 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.0213987 |
| 98 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.0083212 |
| 99 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | -0.0065140 |
| 100 | Pancreatic cancer_Homo sapiens_hsa05212 | -0.0022493 |

